Skip to content
Recall Observatory FDA recall evidence

Drug product

Ibuprofen Tablets, USP 200 mg, 6 x 6500 Caplets (Capsule-Shaped Tablets) bulk packed in double polybag shipper packs for further packaging, Rx only, Manufactured by: Marksans Pharma Ltd., Plot No. L-82, L-83, Verna Indl. Estate, Verna, Goa - 403 722, India, NDC 25000-117-30.

D-0235-2018

January 09, 2018

Class II

Product summary

Firm
Marksans Pharma Inc.
Event
Event 78822
Status
Terminated
Classification
Class II
Quantity
2,853,500 Caplets
Official record key
drug-enforcement:D-0235-2018

Official wording

Reason: CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Code information: Lot #: HH6001, HH6002, Exp 04/18

Distribution pattern: Distributed to repackaging firms in NY who then distributed Nationwide in the USA.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations